Skip to main content
. Author manuscript; available in PMC: 2013 Sep 13.
Published in final edited form as: Arch Neurol. 2012 Jul;69(7):824–831. doi: 10.1001/archneurol.2011.1841

Table 1.

Baseline characteristics of studies

Study Design Outcomes No.
at
risk
No. of
Events
Mean
Age
Sex
(female)
Follow-
up
time
(yrs)
Adjusted For Dementia AD
Dem. AD RR
(Aβ42)
RR
(Aβ42:Aβ40)
RR
(Aβ42)
RR
(Aβ42:Aβ40)
Abdullah 2009 cohort AD 203 -- 14 76.8 48.3% 2.1 (median) age, sex, education -- -- 4.47 (1.19,9.85) 3.91 (1.36,11.24)
Graff-Radford 2007 cohort AD, cognitive change 563 -- 17 78.0 (median) 62.0% 3.7 (median) age, APOE -- -- 1.18 (0.50,2.75) 3.08 (1.12,8.3)
Lambert 2009 case-cohort AD, dementia 8414 233 154 74.6 60.4% 4 age, gender, education, site 1.33 (0.97,1.92) 2.00 (1.41,2.78) -- 2.08 (1.30,3.23)
Mayeux 2003 cohort AD 451 -- 86 76.2 68.9% 5 age, education, APOE, Aβ40 level, BMI -- -- 0.4 (0.21,0.77) --
Schupf 2008 cohort AD 1125 -- 104 76.9 68.3% 4.6 (mean) age, sex, APOE, education, ethnicity, BMI, cohort membership -- -- 0.29 (0.12,0.71) 1.11 (0.59,2.00)
Seppalla 2010a cohort Dementia 197 9c -- 70.0a 55.0%a 3 unknown 3.12 (1.25,7.79) 3.26 (1.31,8.11) -- --
Seppalla 2010b cohort Dementia 60 7c -- 70.0a 55.0%a 6 unknown 4.77 (1.14,19.98) 8.4 (1.83,83.57) -- --
Sundelof 2008a cohort AD, dementia 1045 146 82 71.0 0.0% 11.2 (median) age, APOE 0.7 (0.44,1.13) 0.67 (0.42,1.08) 0.85 (0.48,1.50) 0.89 (0.54,1.48)
Sundelof 2008b cohort AD, dementia 680 74 46 77.6 0.0% 5.3 (median) AD: age dementia: age, APOE, diabetes 1.58 (0.87,2.86) 1.06 (0.59,1.90) 2.5 (1.04,6.03) 1.27 (0.61,2.66)
van Oijen 2006b case-cohort AD, dementia 6713 392 289 68.6 61.0% 8.6 (mean) age, sex 1.16 (0.82,1.64) 2.13 (1.49,3.03) -- --

Abbreviations: AD = Alzheimer’s disease; Aβ = Amyloid beta; APOE = Apolipoprotein E; BMI = Body Mass Index; Dem = Dementia

a

study population data is for entire cohort

b

only continuous RR reported for AD outcome

c

number of events estimated from published data

Note: confidence intervals reflect published results, before random-effects weighting